Yestar Healthcare Holdings Past Earnings Performance
Past criteria checks 3/6
Yestar Healthcare Holdings has been growing earnings at an average annual rate of 17.1%, while the Medical Equipment industry saw earnings growing at 14.7% annually. Revenues have been declining at an average rate of 11.5% per year. Yestar Healthcare Holdings's return on equity is 160%, and it has net margins of 39.7%.
Key information
17.1%
Earnings growth rate
16.9%
EPS growth rate
| Medical Equipment Industry Growth | 13.7% |
| Revenue growth rate | -11.5% |
| Return on equity | 160.0% |
| Net Margin | 39.7% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
These 4 Measures Indicate That Yestar Healthcare Holdings (HKG:2393) Is Using Debt Extensively
Nov 21
Yestar Healthcare Holdings' (HKG:2393) Attractive Earnings Are Not All Good News For Shareholders
Sep 19Yestar Healthcare Holdings (HKG:2393) Seems To Be Using A Lot Of Debt
Dec 13These Return Metrics Don't Make Yestar Healthcare Holdings (HKG:2393) Look Too Strong
Oct 18Is Yestar Healthcare Holdings (HKG:2393) Using Too Much Debt?
Sep 05One Yestar Healthcare Holdings Company Limited (HKG:2393) Analyst Has Been Cutting Their Forecasts
Sep 05Returns On Capital At Yestar Healthcare Holdings (HKG:2393) Have Hit The Brakes
Jun 10These 4 Measures Indicate That Yestar Healthcare Holdings (HKG:2393) Is Using Debt Extensively
Apr 18What Kind Of Investors Own Most Of Yestar Healthcare Holdings Company Limited (HKG:2393)?
Mar 15The Returns At Yestar Healthcare Holdings (HKG:2393) Provide Us With Signs Of What's To Come
Feb 07A Look At Yestar Healthcare Holdings' (HKG:2393) Share Price Returns
Dec 21Do Institutions Own Yestar Healthcare Holdings Company Limited (HKG:2393) Shares?
Nov 30
Revenue & Expenses Breakdown
How Yestar Healthcare Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 2,714 | 1,078 | 331 | 0 |
| 31 Mar 24 | 2,813 | 534 | 336 | 0 |
| 31 Dec 23 | 2,913 | -9 | 342 | 0 |
| 30 Jun 23 | 2,311 | -294 | 381 | 0 |
| 31 Mar 23 | 2,558 | -377 | 443 | 0 |
| 31 Dec 22 | 2,805 | -460 | 504 | 0 |
| 30 Sep 22 | 4,434 | -633 | 722 | 0 |
| 30 Jun 22 | 4,574 | -274 | 658 | 0 |
| 31 Mar 22 | 4,752 | -135 | 661 | 0 |
| 31 Dec 21 | 4,931 | 3 | 664 | 0 |
| 30 Sep 21 | 4,879 | 83 | 663 | 0 |
| 30 Jun 21 | 4,827 | 162 | 662 | 0 |
| 31 Mar 21 | 4,467 | -214 | 655 | 0 |
| 31 Dec 20 | 4,107 | -590 | 649 | 0 |
| 30 Sep 20 | 4,163 | -585 | 652 | 0 |
| 30 Jun 20 | 4,218 | -580 | 655 | 0 |
| 31 Mar 20 | 4,561 | -188 | 655 | 0 |
| 31 Dec 19 | 4,903 | 203 | 654 | 0 |
| 30 Sep 19 | 4,798 | 239 | 618 | 0 |
| 30 Jun 19 | 4,692 | 275 | 582 | 0 |
| 31 Mar 19 | 4,569 | 264 | 565 | 0 |
| 31 Dec 18 | 4,447 | 252 | 549 | 0 |
| 30 Sep 18 | 4,327 | 257 | 525 | 0 |
| 30 Jun 18 | 4,206 | 261 | 502 | 0 |
| 31 Mar 18 | 4,067 | 256 | 481 | 0 |
| 31 Dec 17 | 3,927 | 250 | 460 | 0 |
| 30 Sep 17 | 3,637 | 226 | 436 | 0 |
| 30 Jun 17 | 3,348 | 202 | 411 | 0 |
| 31 Mar 17 | 3,185 | 201 | 377 | 0 |
| 31 Dec 16 | 3,022 | 201 | 343 | 0 |
| 30 Sep 16 | 2,957 | 207 | 321 | 0 |
| 30 Jun 16 | 2,892 | 213 | 298 | 0 |
| 31 Mar 16 | 2,673 | 188 | 262 | 0 |
| 31 Dec 15 | 2,455 | 163 | 225 | 0 |
| 30 Sep 15 | 2,146 | 141 | 181 | 0 |
| 30 Jun 15 | 1,837 | 119 | 137 | 0 |
| 31 Mar 15 | 1,684 | 110 | 127 | 0 |
| 31 Dec 14 | 1,531 | 101 | 116 | 0 |
| 30 Sep 14 | 1,442 | 87 | 119 | 0 |
| 30 Jun 14 | 1,352 | 74 | 122 | 0 |
| 31 Mar 14 | 1,263 | 69 | 119 | 0 |
| 31 Dec 13 | 1,173 | 65 | 115 | 0 |
Quality Earnings: 2393 has a high level of non-cash earnings.
Growing Profit Margin: 2393 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 2393's earnings have grown by 17.1% per year over the past 5 years.
Accelerating Growth: 2393 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 2393 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-4.3%).
Return on Equity
High ROE: 2393's Return on Equity (160%) is considered outstanding.